Loading
Establishment Labs makes Motiva breast implants and tissue expanders, approved in the United States in 2024.
Establishment Labs S.A. is registered with the FDA at Coyol, Alajuela, Costa Rica. Motiva USA, LLC holds PMA P230005 for Motiva SmoothSilk silicone gel-filled breast implants (approved 26 September 2024) and 510(k) K211676 for the Motiva Flora SmoothSilk tissue expander (13 October 2023).
Shares Breast tissue expanders (saline and carbon dioxide), Breast implants for reconstruction (silicone gel, saline and shaped cohesive gel) and the tag devices-gaps-2026-11.
Shares Breast implants for reconstruction (silicone gel, saline and shaped cohesive gel) and the tag devices-gaps-2026-11.
Shares Breast implants for reconstruction (silicone gel, saline and shaped cohesive gel) and the tag devices-gaps-2026-11.
Shares Breast implants for reconstruction (silicone gel, saline and shaped cohesive gel) and the tag devices-gaps-2026-11.
Shares Breast implants for reconstruction (silicone gel, saline and shaped cohesive gel) and the tag devices-gaps-2026-11.
Shares Breast tissue expanders (saline and carbon dioxide), Breast implants for reconstruction (silicone gel, saline and shaped cohesive gel).
Shares Breast tissue expanders (saline and carbon dioxide), Breast implants for reconstruction (silicone gel, saline and shaped cohesive gel).
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/